Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-28

FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)

View source ↗

Summary

FDA approves Advagen Pharma Ltd.'s dorzolamide hydrochloride as a generic eye drop for lowering intraocular pressure in glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride (dorzolamide hydrochloride)

Snippet

ORIG AP for DORZOLAMIDE HYDROCHLORIDE (DORZOLAMIDE HYDROCHLORIDE)